Cullinan Therapeutics announced promising Phase 1b/2a trial results for velinotamig, a BCMAxCD3 T cell engager, in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE). Among nine evaluable patients, eight showed significant disease activity reduction, including rapid decreases in proteinuria and complete renal responses in four patients within 24 weeks. The treatment demonstrated a favorable safety profile with manageable side effects. These findings support further global development of velinotamig for autoimmune diseases driven by pathogenic autoantibodies.
Velinotamig, a BCMAxCD3 T Cell Engager, is the subject with new clinical data. For readers following the health sector, here is Pluang's market snapshot as of Nov 08, 2026 22:02 WIB: Of 150 priced US health stocks, 88 rose and 62 fell. Notable movers include DNA (Ginkgo Bioworks Holdings Inc) at USD 11.29 with a 13.35% increase but 100% sell order activity, GMED (Globus Medical Inc. Class A Common Stock) down 12.84% at USD 71.05, and NVAX (Novavax Inc) up 10.22% at USD 10.78 with 87% buy order activity and a typical hold time of 60 days.
CRISPR Therapeutics announced encouraging Phase 1 trial results for zugo-cel, their gene-edited CAR-T cell therapy targeting refractory autoimmune diseases like systemic sclerosis, lupus, and idiopathic inflammatory myopathy. Among 21 patients treate...
At the 13th annual Muhammad Ali Humanitarian Awards in Louisville, Colin Kaepernick was honored as Humanitarian of the Year for his activism and entrepreneurship, including founding literacy platform Lumi and Know Your Rights Camp. The event also rec...
Cabaletta Bio announced Phase 1/2 clinical data for rese-cel, a CAR T cell therapy targeting autoimmune diseases, showing durable benefits without immunomodulators across dermatomyositis, lupus nephritis, and systemic sclerosis patients. All dermatom...
Ripple has partnered with Stripe-owned Privy to introduce embedded wallets on the XRP Ledger, enabling developers to build payment apps supporting XRP, RLUSD, and other assets. This integration allows automated transactions and easier wallet manageme...
UMH Properties, a REIT managing 145 manufactured home communities, reported a 7% year-over-year increase in adjusted EBITDA for Q3, reflecting solid financial performance. The company maintains manageable interest expenses by refinancing old debt at ...
